Enliven Therapeutics Inc. (ELVN) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Enliven Therapeutics Inc.

    NASDAQ: ELVN · Real-Time Price · USD
    19.61
    -0.31 (-1.56%)
    At close: Oct 03, 2025, 3:59 PM
    20.00
    1.99%
    After-hours: Oct 03, 2025, 06:42 PM EDT

    Enliven Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -11.9 -6.87 -2.71 -2.85
    PEG Ratio
    		 1.99 0.10 -0.03 0.11
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 3.42 2.00 -1.33 -1.64
    P/FCF Ratio
    		 -14.46 -8.01 -3.13 -3.64
    P/OCF Ratio
    		 -14.47 -8.03 -3.19 -3.68
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 n/a 0.00 -0.00 -0.00
    Quick Ratio
    		 19.99 10.28 8.00 19.24
    Current Ratio
    		 19.99 10.28 8.00 19.24
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.29 -0.29 0.49 0.58
    Return on Assets
    		 -0.27 -0.26 -0.45 -0.22
    Return on Invested Capital
    		 -0.34 -0.34 -0.5 -0.23
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist